18 August 2025 in Medical Gas Research
Traumatic central nervous system injuries encompass brain and spinal cord injuries. Recent studies have identified hydrogen sulfide (H₂S) as a potent endogenous gasotransmitter with multifaceted roles in neuroprotection and central nervous system repair. In this systematic review, we explore the mechanisms and therapeutic potential of H₂S in traumatic central nervous system injuries, emphasizing its anti-inflammatory, antioxidant, and anti-apoptotic properties. H₂S suppresses inflammation by modulating the nuclear factor-kappa B pathway, shifting microglial polarization to a reparative phenotype. Further, it mitigates oxidative stress by activating the nuclear factor erythroid 2-related factor 2 and mechanistic target of the rapamycin pathway, and inhibiting glutamate-mediated damage. Additionally, H₂S regulates cell death by inhibiting apoptosis, ferroptosis, pyroptosis, and autophagy while promoting axonal growth and microvascular integrity. Emerging H₂S delivery strategies, including slow-releasing donors such as GYY4137 and advanced hydrogel-based systems, address challenges in achieving sustained and targeted therapeutic effects. Although preclinical evidence has demonstrated the promise of H₂S-based therapies, further research is required to optimize delivery methods, investigate concentration-dependent effects, and validate clinical efficacy. This review provides a comprehensive foundation for advancing H₂S as a therapeutic agent in traumatic central nervous system injuries.
12 September 2025 in Journal of Back and Musculoskeletal Rehabilitation
Background: Low back pain (LBP) has emerged as a critical public health concern whose associated disability burden and healthcare expenditures have been persistently escalating among aging populations worldwide. Objective: This global study analyzed the disability burden of LBP among the older population for over three decades and identified interventions specifically targeting older adults. Methods: Repeated cross-sectional data on LBP among individuals aged ≥65 years from the Global Burden of Disease Study 2021 were extracted and compared to age-standardized rates of LBP incidence and disability adjusted life years (DALYs) across various demographic and geographic categories. Results: Countries with a high sociodemographic index (SDI), advanced health systems, and high incomes, including North America and the Latin America and Caribbean region, exhibited the highest incidence rates and DALYs of LBP. Occupational ergonomics is still the primary factor for LBP in countries with low SDI, and minimal health level countries. Body mass index (BMI) was substantially increased in all global subgroups, especially in countries with low–middle SDI, limited health systems, world bank low-income level groups. Conclusion: Advanced economic development and healthcare showed a non-linear correlation with LBP. High BMI is projected to become a predominant modifiable risk factor for LBP progression, highlighting the urgent need for the implementation of lifestyle strategies.